Download PDF
Semin Respir Crit Care Med 2015; 36(05): 756-766
DOI: 10.1055/s-0035-1562901
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pulmonary Sporotrichosis: An Evolving Clinical Paradigm

Ar K. Aung
1   Department of General Medicine, The Alfred Hospital, Melbourne, Victoria, Australia
2   Department of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia
3   Department of Microbiology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia
,
Denis W. Spelman
2   Department of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia
3   Department of Microbiology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia
,
Philip J. Thompson
4   The Lung Health Clinic, Hollywood Hospital and the Sir Charles Gairdner Hospital Nedlands, and The School of Medicine and Pharmacology University of Western Australia, Perth, WA, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
23 September 2015 (online)

    Permissions and Reprints

Abstract

In recent decades, sporotrichosis, caused by thermally dimorphic fungi Sporothrix schenckii complex, has become an emerging infection in many parts of the world. Pulmonary infection with S. schenckii still remains relatively uncommon, possibly due to underrecognition. Pulmonary sporotrichosis presents with distinct clinical and radiological patterns in both immunocompetent and immunocompromised hosts and can often result in significant morbidity and mortality despite treatment. Current understanding regarding S. schenckii biology, epidemiology, immunopathology, clinical diagnostics, and treatment options has been evolving in the recent years with increased availability of molecular sequencing techniques. However, this changing knowledge has not yet been fully translated into a better understanding of the clinical aspects of pulmonary sporotrichosis, as such current management guidelines remain unsupported by high-level clinical evidence. This article examines recent advances in the knowledge of sporotrichosis and its application to the difficult challenges of managing pulmonary sporotrichosis.

Keywords

sporotrichosis - pulmonary infection - radiology - antifungal agents - diagnosis - management
 

  • References

  • 1 Schenck BR, Wantz GE. On refractory subcutaneous abscesses caused by a fungus possibly related to the Sporotricha. Bull Johns Hopkins Hosp 1898; 93: 286-290
    PubMedGoogle Scholar
  • 2 Carmichael J. Chrysosporium and some other aleuriosporic hyphomycetes. Can J Bot 1962; 40 (8) 1137-1173
    CrossrefPubMedGoogle Scholar
  • 3 López-Romero E, Reyes-Montes MdelR, Pérez-Torres A , et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol 2011; 6 (1) 85-102
    CrossrefPubMedGoogle Scholar
  • 4 Barros MB, de Almeida Paes R, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev 2011; 24 (4) 633-654
    CrossrefPubMedGoogle Scholar
  • 5 Pappas PG. Sporotrichosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, , eds. Essentials of Clinical Mycology. New York: Springer; 2011
    CrossrefGoogle Scholar
  • 6 Aung AK, Teh BM, McGrath C, Thompson PJ. Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes. Med Mycol 2013; 51 (5) 534-544
    CrossrefPubMedGoogle Scholar
  • 7 Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore) 1986; 65 (3) 143-153
    CrossrefPubMedGoogle Scholar
  • 8 Comstock C, Wolson AH. Roentgenology of sporotrichosis. Am J Roentgenol Radium Ther Nucl Med 1975; 125 (3) 651-655
    CrossrefPubMedGoogle Scholar
  • 9 Téllez MD, Batista-Duharte A, Portuondo D, Quinello C, Bonne-Hernández R, Carlos IZ. Sporothrix schenckii complex biology: environment and fungal pathogenicity. Microbiology 2014; 160 (Pt 11) 2352-2365
    CrossrefPubMedGoogle Scholar
  • 10 Bustamante B, Campos PE. Endemic sporotrichosis. Curr Opin Infect Dis 2001; 14 (2) 145-149
    CrossrefPubMedGoogle Scholar
  • 11 Lopes-Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc 2006; 78 (2) 293-308
    PubMedGoogle Scholar
  • 12 de Lima Barros MB, de Oliveira Schubach A, Galhardo MCG , et al. Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol 2003; 42 (9) 677-681
    CrossrefPubMedGoogle Scholar
  • 13 Alves SH, Boettcher CS, Oliveira DC , et al. Sporothrix schenckii associated with armadillo hunting in Southern Brazil: epidemiological and antifungal susceptibility profiles. Rev Soc Bras Med Trop 2010; 43 (5) 523-525
    CrossrefPubMedGoogle Scholar
  • 14 Barros MB, Schubach AdeO, do Valle ACF , et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 2004; 38 (4) 529-535
    CrossrefPubMedGoogle Scholar
  • 15 Romeo O, Criseo G. What lies beyond genetic diversity in Sporothrix schenckii species complex? New insights into virulence profiles, immunogenicity and protein secretion in S. schenckii sensu stricto isolates. Virulence 2013; 4 (3) 203-206
    CrossrefPubMedGoogle Scholar
  • 16 Sivagnanam S, Bannan AM, Chen SC, Ralph AP. Sporotrichosis (Sporothrix schenckii infection) in the New South Wales mid-north coast, 2000-2010. Med J Aust 2012; 196 (9) 588-590
    CrossrefPubMedGoogle Scholar
  • 17 Feeney KT, Arthur IH, Whittle AJ, Altman SA, Speers DJ. Outbreak of sporotrichosis, Western Australia. Emerg Infect Dis 2007; 13 (8) 1228-1231
    CrossrefPubMedGoogle Scholar
  • 18 Pappas PG, Tellez I, Deep AE, Nolasco D, Holgado W, Bustamante B. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 2000; 30 (1) 65-70
    CrossrefPubMedGoogle Scholar
  • 19 Quintal D. Sporotrichosis infection on mines of the Witwatersrand. J Cutan Med Surg 2000; 4 (1) 51-54
    PubMedGoogle Scholar
  • 20 Mayorga R, Cáceres A, Toriello C , et al. An endemic area of sporotrichosis in Guatemala [in French]. Sabouraudia 1978; 16 (3) 185-198
    CrossrefPubMedGoogle Scholar
  • 21 Verma S, Verma GK, Singh G , et al. Sporotrichosis in sub-Himalayan India. PLoS Negl Trop Dis 2012; 6 (6) e1673
    CrossrefPubMedGoogle Scholar
  • 22 Oliveira MM, Almeida-Paes R, Gutierrez-Galhardo MC, Zancope-Oliveira RM. Molecular identification of the Sporothrix schenckii complex. Rev Iberoam Micol 2014; 31 (1) 2-6
    CrossrefPubMedGoogle Scholar
  • 23 Arrillaga-Moncrieff I, Capilla J, Mayayo E , et al. Different virulence levels of the species of Sporothrix in a murine model. Clin Microbiol Infect 2009; 15 (7) 651-655
    CrossrefPubMedGoogle Scholar
  • 24 Yang DJ, Krishnan RS, Guillen DR, Schmiege III LM, Leis PF, Hsu S. Disseminated sporotrichosis mimicking sarcoidosis. Int J Dermatol 2006; 45 (4) 450-453
    CrossrefPubMedGoogle Scholar
  • 25 Conti-Díaz IA, Civila E. Exposure of mice to inhalation of pigmented conidia of Sporothrix schenckii . Mycopathol Mycol Appl 1969; 38 (1) 1-6
    CrossrefPubMedGoogle Scholar
  • 26 Lima OC, Figueiredo CC, Previato JO, Mendonça-Previato L, Morandi V, Lopes Bezerra LM. Involvement of fungal cell wall components in adhesion of Sporothrix schenckii to human fibronectin. Infect Immun 2001; 69 (11) 6874-6880
    CrossrefPubMedGoogle Scholar
  • 27 Ruiz-Baca E, Toriello C, Pérez-Torres A, Sabanero-Lopez M, Villagómez-Castro JC, López-Romero E. Isolation and some properties of a glycoprotein of 70 kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix. Med Mycol 2009; 47 (2) 185-196
    CrossrefPubMedGoogle Scholar
  • 28 Nascimento RC, Espíndola NM, Castro RA , et al. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol 2008; 38 (11) 3080-3089
    CrossrefPubMedGoogle Scholar
  • 29 Lima OC, Figueiredo CC, Pereira BA, Coelho MG, Morandi V, Lopes-Bezerra LM. Adhesion of the human pathogen Sporothrix schenckii to several extracellular matrix proteins. Braz J Med Biol Res 1999; 32 (5) 651-657
    CrossrefPubMedGoogle Scholar
  • 30 Negrini TdeC, Ferreira LS, Alegranci P , et al. Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii . Immunol Invest 2013; 42 (1) 36-48
    CrossrefPubMedGoogle Scholar
  • 31 Sassá MF, Ferreira LS, Ribeiro LC, Carlos IZ. Immune response against Sporothrix schenckii in TLR-4-deficient mice. Mycopathologia 2012; 174 (1) 21-30
    CrossrefPubMedGoogle Scholar
  • 32 Vera-Cabrera L, Salinas-Carmona MC, Waksman N, Messeguer-Pérez J, Ocampo-Candiani J, Welsh O. Host defenses in subcutaneous mycoses. Clin Dermatol 2012; 30 (4) 382-388
    CrossrefPubMedGoogle Scholar
  • 33 Martínez-Álvarez JA, Pérez-García LA, Flores-Carreón A, Mora-Montes HM. The immune response against Candida spp. and Sporothrix schenckii . Rev Iberoam Micol 2014; 31 (1) 62-66
    CrossrefPubMedGoogle Scholar
  • 34 Romo-Lozano Y, Hernández-Hernández F, Salinas E. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Scand J Immunol 2012; 76 (1) 11-20
    CrossrefPubMedGoogle Scholar
  • 35 Maia DCG, Sassá MF, Placeres MCP, Carlos IZ. Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii . Mycopathologia 2006; 161 (1) 11-19
    CrossrefPubMedGoogle Scholar
  • 36 Kusuhara M, Qian H, Li X , et al. Mouse bone marrow-derived dendritic cells can phagocytize the Sporothrix schenckii, and mature and activate the immune response by secreting interleukin-12 and presenting antigens to T lymphocytes. J Dermatol 2014; 41 (5) 386-392
    CrossrefPubMedGoogle Scholar
  • 37 Verdan FF, Faleiros JC, Ferreira LS , et al. Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro. Immunobiology 2012; 217 (8) 788-794
    CrossrefPubMedGoogle Scholar
  • 38 Uenotsuchi T, Takeuchi S, Matsuda T , et al. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int Immunol 2006; 18 (12) 1637-1646
    CrossrefPubMedGoogle Scholar
  • 39 Henry LR, Danaher PJ, Boseley ME. Laryngeal sporotrichosis mimicking Merkel cell carcinoma recurrence. Otolaryngol Head Neck Surg 2005; 132 (2) 336-338
    CrossrefPubMedGoogle Scholar
  • 40 Zhou CH, Asuncion A, Love GL. Laryngeal and respiratory tract sporotrichosis and steroid inhaler use. Arch Pathol Lab Med 2003; 127 (7) 893-894
    PubMedGoogle Scholar
  • 41 Khabie N, Boyce TG, Roberts GD, Thompson DM. Laryngeal sporotrichosis causing stridor in a young child. Int J Pediatr Otorhinolaryngol 2003; 67 (7) 819-823
    CrossrefPubMedGoogle Scholar
  • 42 Agger WA, Seager GM. Granulomas of the vocal cords caused by Sporothrix schenckii . Laryngoscope 1985; 95 (5) 595-596
    PubMedGoogle Scholar
  • 43 Kumar R, Kaushal V, Chopra H , et al. Pansinusitis due to Sporothrix schenckii . Mycoses 2005; 48 (1) 85-88
    CrossrefPubMedGoogle Scholar
  • 44 Morgan M, Reves R. Invasive sinusitis due to Sporothrix schenckii in a patient with AIDS. Clin Infect Dis 1996; 23 (6) 1319-1320
    CrossrefPubMedGoogle Scholar
  • 45 Pueringer RJ, Iber C, Deike MA, Davies SF. Spontaneous remission of extensive pulmonary sporotrichosis. Ann Intern Med 1986; 104 (3) 366-367
    CrossrefPubMedGoogle Scholar
  • 46 Beland JE, Mankiewicz E, MacIntosh DJ. Primary pulmonary sporotrichosis. Can Med Assoc J 1968; 99 (16) 813-816
    PubMedGoogle Scholar
  • 47 Arango C, Davila E, Greenman R. Multifocal sporotrichosis presenting with lobar pulmonary consolidation. South Med J 1981; 74 (6) 755-757
    CrossrefPubMedGoogle Scholar
  • 48 Rocha MM, Dassin T, Lira R, Lima EL, Severo LC, Londero AT. Sporotrichosis in patient with AIDS: report of a case and review. Rev Iberoam Micol 2001; 18 (3) 133-136
    PubMedGoogle Scholar
  • 49 McGavran MH, Kobayashi G, Newmark L, Newberry M, Miller CA, Harford CG. Pulmonary sporotrichosis. Dis Chest 1969; 56 (6) 547-549
    CrossrefPubMedGoogle Scholar
  • 50 England DM, Hochholzer L. Primary pulmonary sporotrichosis. Report of eight cases with clinicopathologic review. Am J Surg Pathol 1985; 9 (3) 193-204
    CrossrefPubMedGoogle Scholar
  • 51 Farley ML, Fagan MF, Mabry LC, Wallace Jr RJ. Presentation of Sporothrix schenckii in pulmonary cytology specimens. Acta Cytol 1991; 35 (4) 389-395
    PubMedGoogle Scholar
  • 52 Serstock DS, Zinnerman HH. Pulmonary and articular sporotrichosis. Report of two cases. JAMA 1975; 233 (12) 1291-1293
    CrossrefPubMedGoogle Scholar
  • 53 Baum GL, Donnerberg RL, Stewart D, Mulligan WJ, Putnam LR. Pulmonary sporotrichosis. N Engl J Med 1969; 280 (8) 410-413
    CrossrefPubMedGoogle Scholar
  • 54 Jung JY, Almond CH, Campbell DC, Elkadi A, Tenorio A. Role of surgery in the management of pulmonary sporotrichosis. J Thorac Cardiovasc Surg 1979; 77 (2) 234-239
    PubMedGoogle Scholar
  • 55 Heller HM, Fuhrer J. Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS 1991; 5 (10) 1243-1246
    CrossrefPubMedGoogle Scholar
  • 56 Mohr JA, Patterson CD, Eaton BG, Rhoades ER, Nichols NB. Primary pulmonary sporotrichosis. Am Rev Respir Dis 1972; 106 (2) 260-264
    CrossrefPubMedGoogle Scholar
  • 57 Losman J-A, Cavanaugh K. Cases from the Osler Medical Service at Johns Hopkins University. Diagnosis: P. carinii pneumonia and primary pulmonary sporotrichosis. Am J Med 2004; 117 (5) 353-356
    CrossrefPubMedGoogle Scholar
  • 58 Kobayashi G, Newmark LN. Pulmonary sporotrichosis. JAMA 1969; 210 (9) 1741-1744
    CrossrefPubMedGoogle Scholar
  • 59 Tambini R, Farina C, Fiocchi R , et al. Possible pathogenic role for Sporothrix cyanescens isolated from a lung lesion in a heart transplant patient. J Med Vet Mycol 1996; 34 (3) 195-198
    CrossrefPubMedGoogle Scholar
  • 60 Gerding DN. Treatment of pulmonary sporotrichosis. Semin Respir Infect 1986; 1 (1) 61-65
    PubMedGoogle Scholar
  • 61 Khan FA, Guarneri JJ, Sierra MF. Primary pulmonary sporotrichosis complicated by perirectal abscess. Am Rev Respir Dis 1975; 112 (1) 119-123
    PubMedGoogle Scholar
  • 62 Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol 2007; 25 (2) 181-187
    CrossrefPubMedGoogle Scholar
  • 63 Morrissey R, Caso R. Pleural sporotrichosis. Chest 1983; 84 (4) 507
    CrossrefPubMedGoogle Scholar
  • 64 Rex JH. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved Standard. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008
    Google Scholar
  • 65 Rodriguez-Tudela J, Donnelly J, Arendrup M , et al; Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008; 14 (10) 982-984
    CrossrefPubMedGoogle Scholar
  • 66 Karlin JV, Nielsen Jr HS. Serologic aspects of sporotrichosis. J Infect Dis 1970; 121 (3) 316-327
    CrossrefPubMedGoogle Scholar
  • 67 Oliveira MME, Almeida-Paes R, Gutierrez-Galhardo MC, Zancope-Oliveira RM. Molecular identification of the Sporothrix schenckii complex. Rev Iberoam Micol 2014; 31 (1) 2-6
    CrossrefPubMedGoogle Scholar
  • 68 Steele RW, Cannady Jr PB, Moore Jr WL, Gentry LO. Skin test and blastogenic responses to Sporotrichun schenckii . J Clin Invest 1976; 57 (1) 156-160
    CrossrefPubMedGoogle Scholar
  • 69 Hu S, Chung W-H, Hung S-I , et al. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J Clin Microbiol 2003; 41 (4) 1414-1418
    CrossrefPubMedGoogle Scholar
  • 70 Liu X, Zhang Z, Hou B , et al. Rapid identification of Sporothrix schenckii in biopsy tissue by PCR. J Eur Acad Dermatol Venereol 2013; 27 (12) 1491-1497
    CrossrefPubMedGoogle Scholar
  • 71 Kauffman CA. Sporotrichosis. Clin Infect Dis 1999; 29 (2) 231-236 , quiz 237
    CrossrefPubMedGoogle Scholar
  • 72 Kauffman CA, Bustamante B, Chapman SW, Pappas PG ; Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45 (10) 1255-1265
    CrossrefPubMedGoogle Scholar
  • 73 Limper AH, Knox KS, Sarosi GA , et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011; 183 (1) 96-128
    CrossrefPubMedGoogle Scholar
  • 74 de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaes de Oliveira R, Martins EB, Teixeira JL, Wanke B. Treatment of cutaneous sporotrichosis with itraconazole—study of 645 patients. Clin Infect Dis 2011; 52 (12) e200-e206
    CrossrefPubMedGoogle Scholar
  • 75 Conte Jr JE, Golden JA, Kipps J, McIver M, Zurlinden E. Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state. Antimicrob Agents Chemother 2004; 48 (10) 3823-3827
    CrossrefPubMedGoogle Scholar
  • 76 Rodvold KA, Yoo L, George JM. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents. Clin Pharmacokinet 2011; 50 (11) 689-704
    CrossrefPubMedGoogle Scholar
  • 77 Merritt RE, Shrager JB. Indications for surgery in patients with localized pulmonary infection. Thorac Surg Clin 2012; 22 (3) 325-332
    CrossrefPubMedGoogle Scholar
  • 78 LoCicero III J, Shaw JP, Lazzaro RS. Surgery for other pulmonary fungal infections, Actinomyces, and Nocardia. Thorac Surg Clin 2012; 22 (3) 363-374
    CrossrefPubMedGoogle Scholar
  • 79 Marimon R, Serena C, Gené J, Cano J, Guarro J. In vitro antifungal susceptibilities of five species of Sporothrix . Antimicrob Agents Chemother 2008; 52 (2) 732-734
    CrossrefPubMedGoogle Scholar
  • 80 Silveira CP, Torres-Rodríguez JM, Alvarado-Ramírez E , et al. MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii . J Med Microbiol 2009; 58 (Pt 12) 1607-1610
    CrossrefPubMedGoogle Scholar
  • 81 Oliveira DC, Lopes PGM, Spader TB , et al. Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil. J Clin Microbiol 2011; 49 (8) 3047-3049
    CrossrefPubMedGoogle Scholar
  • 82 Rodrigues AM, de Hoog GS, de Cássia Pires D , et al. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect Dis 2014; 14: 219
    CrossrefPubMedGoogle Scholar
  • 83 Borba-Santos LP, Rodrigues AM, Gagini TB , et al. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. Med Mycol 2015; 53 (2) 178-188
    CrossrefPubMedGoogle Scholar
  • 84 Kohler LM, Soares BM, de Assis Santos D, Da Silva Barros ME, Hamdan JS. In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms. Can J Microbiol 2006; 52 (9) 843-847
    CrossrefPubMedGoogle Scholar
  • 85 Kohler LM, Monteiro PCF, Hahn RC, Hamdan JS. In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine. J Clin Microbiol 2004; 42 (9) 4319-4320
    CrossrefPubMedGoogle Scholar
  • 86 Francesconi G, Francesconi do Valle AC, Passos SL , et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia 2011; 171 (5) 349-354
    CrossrefPubMedGoogle Scholar
  • 87 Zhang X, Huang H, Feng P , et al. In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckii . Eur J Dermatol 2011; 21 (4) 573-576
    PubMedGoogle Scholar
  • 88 Ruiz-Baca E, Hernández-Mendoza G, Cuéllar-Cruz M, Toriello C, López-Romero E, Gutiérrez-Sánchez G. Detection of 2 immunoreactive antigens in the cell wall of Sporothrix brasiliensis and Sporothrix globosa . Diagn Microbiol Infect Dis 2014; 79 (3) 328-330
    CrossrefPubMedGoogle Scholar
  • 89 Alba-Fierro CA, Pérez-Torres A, López-Romero E, Cuéllar-Cruz M, Ruiz-Baca E. Cell wall proteins of Sporothrix schenckii as immunoprotective agents. Rev Iberoam Micol 2014; 31 (1) 86-89
    CrossrefPubMedGoogle Scholar
  • 90 Nascimento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol Med Microbiol 2005; 43 (2) 241-247
    CrossrefPubMedGoogle Scholar